SCHEMBL19981479

SCHEMBL19981479

CCOC(=O)/C=C/C(=O)Nc1nncs1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.64
MAPT P10636 5/20 0.64
HTT P42858 1/20 0.64
NPC1 O15118 5/20 0.50
RAB9A P51151 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KDM4E B2RXH2 3/20 0.50
MDM2 Q00987 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.46
THRB P10828 1/20 0.46
POLB P06746 2/20 0.46
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.43
HSP90AA1 P07900 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25100273 0.81 MAPT (0.45) LMNAMAPTHTTSMN1; SMN2KDM4E
SCHEMBL1279996 0.79 POLB (0.52) LMNAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL19981418 0.78 MAPT (0.64) LMNAMAPTHTTNPC1RAB9A
SCHEMBL19974284 0.78 MAPT (1.00) LMNAMAPTHTTNPC1RAB9A
SCHEMBL19974323 0.77 NPC1 (0.58) LMNAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL19974322 0.77 NPC1 (0.58) LMNAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL17777273 0.77 L3MBTL1 (0.48) LMNAMAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL25478125 0.75 MAPT (0.57) LMNAMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL23647324 0.75 MAPT (0.64) LMNAMAPTHTTNPC1RAB9A
SCHEMBL19974150 0.74 LMNA (0.58) LMNAMAPTHTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LMNA 3549/4885MAPT 2930/4885HTT 1981/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LMNA 3549/4885MAPT 2930/4885HTT 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.